Latham & Watkins advised Harmony Biosciences, while Paul Hastings LLP advised J.P. Morgan as the sole book-running manager in the offering. Harmony Biosciences Holdings, Inc. (Nasdaq:...
You must be a Standard 1 Year member to access this content.
Weil, Gotshal and Manges advised American Securities LLC, while Latham & Watkins represented Jefferies in a financing to support the acquisition. American Securities LLC, a leading...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented Flame Acquisition Corp. in the transaction, while Bracewell advised Sable Offshore Corp. Flame Acquisition Corp. (Flame) (NYSE: FLME, FLME.WS), a special purpose acquisition...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented TransUnion in the transaction while Sidley advised nThrive. TransUnion (NYSE: TRU) has signed a definitive agreement to sell TransUnion Healthcare, Inc. to...
You must be a Standard 1 Year member to access this content.
Dentons and Latham & Watkins advised ATAI Life Sciences on the deal, while Davis Polk advised the underwriters. Clinical-stage biopharmaceutical company ATAI Life Sciences launched its...
You must be a Standard 1 Year member to access this content.
Vinson & Elkins LLP and Clifford Chance advised Decarbonization Plus Acquisition Corporation II on the business combination with Tritium Holdings Pty Ltd, represented by Corrs Chambers...
You must be a Standard 1 Year member to access this content.
